A detailed history of Caprock Group, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, Caprock Group, Inc. holds 7,851 shares of TWST stock, worth $340,733. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,851
Previous 7,631 2.88%
Holding current value
$340,733
Previous $261,000 47.89%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$27.95 - $53.0 $6,149 - $11,660
220 Added 2.88%
7,851 $386,000
Q1 2024

Apr 29, 2024

SELL
$32.28 - $41.5 $322 - $415
-10 Reduced 0.13%
7,631 $261,000
Q4 2023

Jan 18, 2024

BUY
$15.08 - $38.61 $115,226 - $295,019
7,641 New
7,641 $281,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.45B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.